Skip to main content

Agilent to Collaborate with FDA on Food Pathogen Testing

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with the US Food and Drug Administration on food testing applications.

Under a Cooperative Research and Development Agreement with the FDA, Agilent will aim to develop new DNA-based tools for detecting and analyzing pathogens in food. The first part of the project is focused on developing an assay panel, using mass spectrometry-based genotyping, to identify subtypes of salmonella in food.

Agilent said that it also has signed a second agreement with the FDA and the Campden BRI laboratory in the UK to update Agilent's lab-on-a-chip method of DNA analysis to identify fish species and ensure that seafood is correctly labeled. The technology is based on the Agilent Bioanalyzer, which uses fragment length polymorphism. The partners aim to devise a method that is fast and inexpensive but "simple enough that many kinds of laboratories can use it on a routine basis."

Terms of the agreements were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.